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1. INTRODUCTION {#mgg31247-sec-0005}
===============

Lumbar disk herniation (LDH) is one of the most common orthopedic disorders. LDH is mainly caused by the degenerative changes in various parts of the lumbar disk, including central nucleus pulposus, ring annulus fibrosus, and cartilage (Mio et al., [2007](#mgg31247-bib-0014){ref-type="ref"}). Under the action of external factors, annulus fibrosus may be disrupted, and nucleus pulposus may further protrude or prolapse from the rupture to the rear or spinal canal. These situations will lead to the stimulation or oppression of adjacent spinal nerve root, and resulting in backaches, numbness of lower extremity, and a series of clinical symptoms (Vialle, Vialle, Henao, & Giraldo, [2010](#mgg31247-bib-0020){ref-type="ref"}). LDH make patients suffer from low living quality and high health care costs (Eskola et al., [2012](#mgg31247-bib-0008){ref-type="ref"}). Although several risk factors associated with LDH have been reported in epidemiologic studies (Andersson, [1998](#mgg31247-bib-0001){ref-type="ref"}), the pathogenesis and etiology of LDH is still unclear. However, twins studies showed that more than 70% of the LDH patients have a positive family history (Battié, Videman, Levälahti, Gill, & Kaprio, [2008](#mgg31247-bib-0004){ref-type="ref"}), which arouse researchers' interest to identify genes associated with development of LDH.

Previous literatures have reported several types of susceptibility genes for LDH, including structural, catabolic, and inflammatory‐related genes (Mayer et al., [2013](#mgg31247-bib-0013){ref-type="ref"}). The nucleus pulposus and annulus fibrosus of lumbar disk are mainly composed of type I and type II collagen (Le, Freemont, & Hoyland, [2005](#mgg31247-bib-0012){ref-type="ref"}; Sive et al., [2002](#mgg31247-bib-0017){ref-type="ref"}). Some researchers believed that excessive degradation and fibrosis of type I and type II collagen will lead to LDH, and the catabolic processes are actually regulated by a series of cytokines (Watanabe et al., [2003](#mgg31247-bib-0021){ref-type="ref"}). Interleukin (IL)‐1 is a cytokine superfamily, which has been reported that involved in the inflammatory process and immune response in human body (Balasubramanian et al., [2006](#mgg31247-bib-0003){ref-type="ref"}). IL‐1 cytokine family included IL‐1ɑ, IL‐1β, and IL‐1 receptor antagonist (IL‐1Ra), which encoded by *IL1A*, *IL1B*, and *IL1RN*, respectively. The level of IL‐1β has been found increased in the collagen of LDH patients (Attur et al., [2002](#mgg31247-bib-0002){ref-type="ref"}). Moreover, polymorphisms of *IL1B* and *IL1RN* were associated with risk of LDH in a Finland population (Solovieva et al., [2004](#mgg31247-bib-0018){ref-type="ref"}). However, to date, little information is found about the correlation of *IL1RN* (OMIM:147679) polymorphisms and LDH risk in the Chinese population.

Age was a major risk factor for LDH. Therefore, in this study, the individuals were divided to two groups based on their age. We attempted to investigate the candidate SNPs and their interaction with age that may have correlation with LDH risk in Chinese Han samples.

2. MATERIALS AND METHODS {#mgg31247-sec-0006}
========================

2.1. Subjects {#mgg31247-sec-0007}
-------------

All subjects in our study were unrelated Han Chinese individuals and coming from Shaanxi Province of China. The overall number of 498 LDH patients and 463 healthy individuals were recruited between September 2015 and September 2017 at the Xi\'an Jiaotong University Hospital Medical College Red Cross Hospital. All the patients were recently diagnosed with LDH according to the magnetic resonance imaging (sagittal and axial images obtained with a 1.5‐T imaging system), and a history of unilateral pain from the femoral or sciatic nerve to the corresponding dermatome of the nerve root for more than 3 months. Patients with trauma‐related LDH, rheumatic, spinal tumor, or spondylitis were excluded. The controls were randomly recruited healthy individuals. We excluded those with known disease or cancers.

All subjects were at least 18 years old and were in good mental condition. The Human Research Committee for Approval of Research Involving Human Subjects, Xi\'an Jiaotong University Hospital Medical College Red Cross Hospital, approved the use of human blood samples in this study. The written informed consent was signed by all of them.

2.2. SNP genotyping {#mgg31247-sec-0008}
-------------------

Candidate SNPs were selected from DisGenet database (<http://www.disgenet.org/>). First, we selected SNPs in *IL1RN* that associated with other types of disease. Then, we excluded those SNPs with minor allele frequencies under 5% in the CHB population of 1,000 genome project (<http://www.internationalgenome.org/>). Finally, five SNPs (rs17042888, rs315919, rs928940, rs3181052, and rs452204) in *IL1RN* were selected for our study. To date, these SNPs have not been reported for LDH susceptibility. Genomic DNA was prepared from peripheral blood samples using the GoldMag‐Mini Purification Kit (GoldMag Co. Ltd.), following the manufacturer\'s instructions. DNA concentrations were measured by NanoDrop 2000 (Thermo Scientific) at a wavelength value of A260 and A280 nm. Primers for amplification process and single base extension reactions were designed using the Sequenom MassARRAY Assay Design 3.0 software. SNP genotyping was performed by Sequenom MassARRAY RS1000 (Sequenom) (Thomas et al., [2007](#mgg31247-bib-0019){ref-type="ref"}). Finally, Sequenom Typer 4.0 software (Sequenom) was used to perform data management and analyses (Gabriel, Ziaugra, & Tabbaa, [2009](#mgg31247-bib-0009){ref-type="ref"}).

2.3. Statistical analyses {#mgg31247-sec-0009}
-------------------------

All of the statistical analyses were performed with Microsoft Excel (Microsoft Corporation) and the SPSS 21.0 statistical package (SPSS, Chicago, IL, USA). The Hardy--Weinberg Equilibrium (HWE) test was used for the controls before analysis. Differences between the cases and controls in the distributions of gender, age, and allele frequencies of the SNPs were evaluated using *χ* ^2^ tests and Welch\'s *t* tests. The subjects were divided into two groups: younger group and elder group based on their age. Associations between the genotypes of SNPs and LDH susceptibility were evaluated by odds ratios (ORs) and 95% confidence intervals (CIs). Four genetic models (codominant, dominant, recessive, and log‐additive) were used to assess the associations. All *p* values were two sided, and *p* values under .05 were considered to be statistical significance.

3. RESULTS {#mgg31247-sec-0010}
==========

The overall number of 498 LDH patients and 463 healthy individuals were included in the study. The gender and age of two groups are described in Table [1](#mgg31247-tbl-0001){ref-type="table"}. The mean age of the participants was 50.27 ± 12.53 years in the case group and 50.65 ± 11.8 years in the control group. No significant difference in the distribution of gender and age was observed between two groups (*p* \> .05).

###### 

Distributions of age and gender in LDH patients and controls

  Variables     cases(*N* = 498)   \%     Controls (*N* = 463)   \%     *p*
  ------------- ------------------ ------ ---------------------- ------ ------
  Gender                                                                .413
  Female        200                40.2   198                    42.8   
  Male          298                59.8   265                    57.2   
  Age                                                                   .978
  Mean ± *SD*   50.27 ± 12.53             50.65 ± 11.8                  .964
  ≤50           233                46.8   216                    46.7   
  \>50          265                53.2   247                    53.3   

*p* values were calculated from *χ* ^2^ test/student\'s *t* test.
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The basic information of the *IL1RN* polymorphisms (rs17042888, rs315919, rs928940, rs3181052, and rs452204) is shown in Table [2](#mgg31247-tbl-0002){ref-type="table"}, including gene, band, position, role, alleles, and minor allele frequency (MAF). We compared the difference in frequency distributions of alleles between LDH cases and controls by Chi‐squared test. However, no associations were observed between the alleles and LDH risk.

###### 

Basic information of candidate SNPs in this study

  SNP ID       Gene      Band   Position    Role     Alleles A/B   MAF     *p*‐HWE   OR(95% CI)                                       *p* [^a^](#mgg31247-note-0004){ref-type="fn"}   
  ------------ --------- ------ ----------- -------- ------------- ------- --------- ------------------------------------------------ ----------------------------------------------- ------
  rs17042888   *IL1RN*   2q13   113862173   Intron   A/G           0.239   0.261     .47                                              0.89 (0.72--1.09)                               .257
  rs315919     *IL1RN*   2q13   113876213   Intron   T/G           0.391   0.411     .63                                              0.92 (0.77--1.10)                               .370
  rs928940     *IL1RN*   2q13   113877495   Intron   T/G           0.375   0.393     \<.05[^b^](#mgg31247-note-0005){ref-type="fn"}   0.93 (0.77--1.12)                               .428
  rs3181052    *IL1RN*   2q13   113886049   Intron   G/A           0.377   0.406     .25                                              0.88 (0.74--1.06)                               .185
  rs452204     *IL1RN*   2q13   113889061   Intron   G/A           0.335   0.348     1                                                0.95 (0.78--1.14)                               .555

Abbreviations: Alleles A/B, Minor/major alleles; CI, confidence interval; HWE, Hardy--Weinberg equilibrium; MAF, minor allele frequency; OR, odds ratio; SNP, single‐nucleotide polymorphism.

*p* values were calculated using two‐sided Chi‐squared test.

*p*‐HWE \< .05 was excluded from the study.
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The subjects were divided into two groups based on their age: younger group and elder group. The MAFs of SNPs in younger and elder groups are listed in Table [3](#mgg31247-tbl-0003){ref-type="table"}. We found one significant SNP was associated with LDH risk in elder group. The frequency of the "A" allele of rs17042888 was significantly lower in elder LDH cases than in controls (0.219 versus. 0.279), which suggested that "A" allele of rs17042888 was a protective allele against LDH risk (OR = 0.72, 95%CI: 0.54--0.96, *p* = .025).

###### 

Minor allele frequency of SNPs in younger and elder groups

  SNP ID       Alleles A/B   Younger group (≤50)   Elder group (\>50)                                                                                                                                                                   
  ------------ ------------- --------------------- -------------------- ---------------------------------------------- ------------------- ------ ------- ------- ------------------------------------------------ -------------------- ------------------------------------------------
  rs17042888   A/G           0.262                 0.241                .47                                            1.12 (0.83--1.51)   .467   0.219   0.279   .75                                              0.72 (0.54--0.96)    .025[^\*^](#mgg31247-note-0050){ref-type="fn"}
  rs315919     T/G           0.391                 0.39                 .89                                            1.01 (0.77--1.31)   .991   0.391   0.429   .60                                              0.86 (0.67--1.10)    .217
  rs928940     T/G           0.363                 0.377                .01[^b^](#mgg31247-note-0008){ref-type="fn"}   0.94 (0.72--1.24)   .663   0.386   0.407   \<.05[^b^](#mgg31247-note-0008){ref-type="fn"}   0.92 (0.71--1.18)    .503
  rs3181052    G/A           0.363                 0.398                .79                                            0.86(0.66--1.13)    .274   0.389   0.413   .25                                              0.90 (0.70--1.16)    .428
  rs452204     G/A           0.33                  0.322                .53                                            1.03 (0.78--1.37)   .816   0.340   0.370   .78                                              0.88 (0.68--1.138)   .312

Abbreviations: Alleles A/B, Minor/major alleles; CI, confidence interval; HWE, Hardy--Weinberg equilibrium; MAF, minor allele frequency; OR, odds ratio; SNP, single‐nucleotide polymorphism.

*p* values were calculated using two‐sided Chi‐squared test.

*p*‐HWE \< .05 was excluded from the study.

*p* value \< .05 indicates statistical significance.
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Next, we assumed that the major allele of each SNP was a reference allele and calculated the OR and 95%CI between each variant and LDH risk under four genetic models (Table [4](#mgg31247-tbl-0004){ref-type="table"}). We found that rs3181052 was associated with LDH risk under the dominant model. Compared with rs3181052 AA genotype, carriers of AG and GG exhibited a lower risk of LDH (OR = 0.74, 95%CI: 0.57--0.96, *p* = .025).

###### 

Genotypes frequencies of the SNPs and their associations with risk of LDH

  Model          Genotype      Control       Case                OR (95% CI)         *p* value
  -------------- ------------- ------------- ------------------- ------------------- ----------------------------------------------
  rs17042888                                                                         
  Codominant     G/G           249 (53.8%)   280 (56.2%)         1                   .310
  A/G            186 (40.2%)   198 (39.8%)   0.95 (0.73--1.23)                       
  A/A            28 (6%)       20 (4%)       0.63 (0.34--1.14)                       
  Dominant       G/G           249 (53.8%)   280 (56.2%)         1                   .440
  A/G‐A/A        214 (46.2%)   218 (43.8%)   0.91 (0.70--1.17)                       
  Recessive      G/G‐A/G       435 (94%)     478 (96%)           1                   .140
  A/A            28 (6%)       20 (4%)       0.64 (0.36--1.16)                       
  Log‐additive   ---           ---           ---                 0.88 (0.71--1.09)   .230
  rs315919                                                                           
  Codominant     T/T           162 (35.3%)   175 (35.1%)         1                   .160
  G/T            217 (47.3%)   257 (51.6%)   1.10 (0.83--1.45)                       
  G/G            80 (17.4%)    66 (13.2%)    0.76 (0.52--1.13)                       
  Dominant       T/T           162 (35.3%)   175 (35.1%)         1                   .960
  G/T‐G/G        297 (64.7%)   323 (64.9%)   1.01 (0.77--1.31)                       
  Recessive      T/T‐G/T       379 (82.6%)   432 (86.8%)         1                   .070
  G/G            80 (17.4%)    66 (13.2%)    0.72 (0.51--1.03)                       
  Log‐additive   ---           ---           ---                 0.92 (0.76--1.10)   .360
  rs3181052                                                                          
  Codominant     A/A           157 (33.9%)   204 (41%)           1                   .034
  A/G            236 (51%)     213 (42.8%)   0.70 (0.53--0.92)                       
  G/G            70 (15.1%)    81 (16.3%)    0.89 (0.61--1.31)                       
  Dominant       A/A           157 (33.9%)   204 (41%)           1                   .025[\*](#mgg31247-note-0010){ref-type="fn"}
  A/G‐G/G        306 (66.1%)   294 (59%)     0.74 (0.57--0.96)                       
  Recessive      A/A‐A/G       393 (84.9%)   417 (83.7%)         1                   .620
  G/G            70 (15.1%)    81 (16.3%)    1.09 (0.77--1.55)                       
  Log‐additive   ---           ---           ---                 0.89 (0.74--1.06)   .190
  rs452204                                                                           
  Codominant     A/A           195 (42.4%)   230 (46.3%)         1                   .270
  A/G            210 (45.6%)   201 (40.4%)   0.81 (0.62--1.07)                       
  G/G            55 (12%)      66 (13.3%)    1.02 (0.68--1.53)                       
  Dominant       A/A           195 (42.4%)   230 (46.3%)         1                   .230
  A/G‐G/G        265 (57.6%)   267 (53.7%)   0.86 (0.66--1.10)                       
  Recessive      A/A‐A/G       405 (88%)     431 (86.7%)         1                   .540
  G/G            55 (12%)      66 (13.3%)    1.13 (0.77--1.65)                       
  Log‐additive   ---           ---           ---                 0.95 (0.79--1.14)   .570

Abbreviations: CI, confidence interval; ORs, odds ratios.

*p* value \< .05 indicates statistical significance.

John Wiley & Sons, Ltd

In the stratified analysis by age, we found two susceptibility SNPs were associated with LDH risk in elder group (Table [5](#mgg31247-tbl-0005){ref-type="table"}). The AG and AA genotypes of rs17042888 were associated with decreased risk of LDH under the dominant model (OR = 0.69, 95%CI: 0.49--0.98, *p* = .038). The GG genotype of rs315919 was identified have correlation with decreased risk of LDH under the recessive model (OR = 0.60, 95%CI: 0.37--0.97, *p* = .034).

###### 

Association between SNPs and risk of LDH in younger and elder groups

  Model          Genotype      younger group(≤50)   elder group (\>50)                                                                                           
  -------------- ------------- -------------------- -------------------- ------------------- ------------- ------------------- ------------- ------------------- ----------------------------------------------
  rs17042888                                                                                                                                                     
  Codominant     G/G           122 (56.5%)          120 (51.5%)          1                   .46           127 (51.4%)         160 (60.4%)   1                   .063
  A/G            84 (38.9%)    104 (44.6%)          1.26 (0.86--1.85)    102 (41.3%)         94 (35.5%)    0.73 (0.51--1.05)                                     
  A/A            10 (4.6%)     9 (3.9%)             0.91 (0.36--2.32)    18 (7.3%)           11 (4.2%)     0.47 (0.21--1.03)                                     
  Dominant       G/G           122 (56.5%)          120 (51.5%)          1                   .29           127 (51.4%)         160 (60.4%)   1                   .038[\*](#mgg31247-note-0012){ref-type="fn"}
  A/G‐A/A        94 (43.5%)    113 (48.5%)          1.22 (0.84--1.77)    120 (48.6%)         105 (39.6%)   0.69 (0.49--0.98)                                     
  Recessive      G/G‐A/G       206 (95.4%)          224 (96.1%)          1                   .68           229 (92.7%)         254 (95.8%)   1                   .1
  A/A            10 (4.6%)     9 (3.9%)             0.83 (0.33--2.07)    18 (7.3%)           11 (4.2%)     0.53 (0.25--1.15)                                     
  Log‐additive   ---           ---                  ---                  1.13 (0.82--1.56)   .44           ---                 ---           0.71 (0.53--0.95)   .02
  rs315919                                                                                                                                                       
  Codominant     T/T           80 (37.4%)           84 (36%)             1                   .86           82 (33.5%)          91 (34.3%)    1                   .096
  G/T            101 (47.2%)   116 (49.8%)          1.09 (0.72--1.63)    116 (47.4%)         141 (53.2%)   1.10 (0.74--1.61)                                     
  G/G            33 (15.4%)    33 (14.2%)           0.95 (0.54--1.69)    47 (19.2%)          33 (12.4%)    0.63 (0.37--1.08)                                     
  Dominant       T/T           80 (37.4%)           84 (36%)             1                   .79           82 (33.5%)          91 (34.3%)    1                   0.83
  G/T‐G/G        134 (62.6%)   149 (64%)            1.05 (0.72--1.55)    163 (66.5%)         174 (65.7%)   0.96 (0.67--1.39)                                     
  Recessive      T/T‐G/T       181 (84.6%)          200 (85.8%)          1                   .71           198 (80.8%)         232 (87.5%)   1                   .034[\*](#mgg31247-note-0012){ref-type="fn"}
  G/G            33 (15.4%)    33 (14.2%)           0.91 (0.54--1.53)    47 (19.2%)          33 (12.4%)    0.60 (0.37--0.97)                                     
  Log‐additive   ---           ---                  ---                  1.00 (0.76--1.31)   1             ---                 ---           0.85 (0.65--1.09)   .2
  rs3181052                                                                                                                                                      
  Codominant     A/A           77 (35.6%)           100 (42.9%)          1                   .24           80 (32.4%)          104 (39.2%)   1                   .12
  A/G            106 (49.1%)   97 (41.6%)           0.70 (0.47--1.06)    130 (52.6%)         116 (43.8%)   0.68 (0.46--1.00)                                     
  G/G            33 (15.3%)    36 (15.4%)           0.85 (0.48--1.48)    37 (15%)            45 (17%)      0.93 (0.55--1.58)                                     
  Dominant       A/A           77 (35.6%)           100 (42.9%)          1                   .12           80 (32.4%)          104 (39.2%)   1                   .099
  A/G‐G/G        139 (64.3%)   133 (57.1%)          0.74 (0.50--1.08)    167 (67.6%)         161 (60.8%)   0.74 (0.51--1.06)                                     
  Recessive      A/A‐A/G       183 (84.7%)          197 (84.5%)          1                   .94           210 (85%)           220 (83%)     1                   .53
  G/G            33 (15.3%)    36 (15.4%)           1.02 (0.61--1.71)    37 (15%)            45 (17%)      1.16 (0.72--1.87)                                     
  Log‐additive   ---           ---                  ---                  0.87 (0.66--1.13)   .29           ---                 ---           0.90 (0.70--1.16)   .42
  rs452204                                                                                                                                                       
  Codominant     A/A           96 (44.9%)           111 (47.8%)          1                   .15           99 (40.2%)          119 (44.9%)   1                   .56
  A/G            98 (45.8%)    89 (38.4%)           0.78 (0.52--1.16)    112 (45.5%)         112 (42.3%)   0.83 (0.57--1.21)                                     
  G/G            20 (9.3%)     32 (13.8%)           1.39 (0.75--2.59)    35 (14.2%)          34 (12.8%)    0.81 (0.47--1.39)                                     
  Dominant       A/A           96 (44.9%)           111 (47.8%)          1                   .51           99 (40.2%)          119 (44.9%)   1                   .29
  A/G‐G/G        118 (55.1%)   121 (52.2%)          0.88 (0.61--1.28)    147 (59.8%)         146 (55.1%)   0.83 (0.58--1.17)                                     
  Recessive      A/A‐A/G       194 (90.7%)          200 (86.2%)          1                   .14           211 (85.8%)         231 (87.2%)   1                   .63
  G/G            20 (9.3%)     32 (13.8%)           1.56 (0.86--2.83)    35 (14.2%)          34 (12.8%)    0.88 (0.53--1.47)                                     
  Log‐additive   ---           ---                  ---                  1.03 (0.78--1.36)   .83           ---                 ---           0.88 (0.68--1.13)   .32

Abbreviations: CI, confidence interval; ORs, odds ratios.

*p* value \< .05 indicates statistical significance.
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4. DISCUSSION {#mgg31247-sec-0011}
=============

Even to this day, the pathogenesis of degeneration of lumbar disk retained poorly investigated. LDH is a very complicated disease, understanding the molecular genetics leading to susceptibility to LDH is very helpful to designing novel targets for clinical prevention and treatment. In the present study, we investigated the associations between five selected *IL1RN* SNPs and LDH risk, and found that the minor alleles of rs17042888, rs315919, and rs3181052 are significantly associated with decreased risk of LDH in a Chinese Han population. The current data suggested that genetic polymorphisms of *IL1RN* may play a protective role against risk of LDH.

It is noteworthy that rs17042888 and rs315919 were associated with risk of LDH in elder group whose age is over 50; but it is not significant in younger group whose age is less than 50. It is widely accepted that degenerative change of collagen types II in nucleus pulposus and collagen I in annulus fibrosus have close correlation with intervertebral disk degeneration (Nerlich, Boos, Wiest, & Aebi, [1998](#mgg31247-bib-0015){ref-type="ref"}). Intervertebral disk degeneration is actually a process of aging (Boos et al., [2002](#mgg31247-bib-0006){ref-type="ref"}). There is a significant difference in the collagenous matrix in the disks between younger and elder (Nerlich et al., [1998](#mgg31247-bib-0015){ref-type="ref"}), which may explain our results and that is also why we divided the subjects into two groups. The results identified here also suggested that age as an important factor need to be considered in the clinical personalized treatment.

According to the report, SNPs can affect gene function through similar or different molecular mechanisms at gene transcription level, posttranscription level, translation level, posttranslation protein folding, and protein cell localization level (Rose, [2008](#mgg31247-bib-0016){ref-type="ref"}). For example, Japanese scholars have discovered through in vivo and in vitro experiments that the transition of an snp(g/a) allelic site on Duchenne muscular dystrophy (dmd) gene from G to A can completely inactivate the splice donor site(Tran et al.). This study investigated five SNPs in *IL1RN*, which have been reported have correlation with several disease in previous literatures. Hosgood et al. reported that rs17042888 and two other SNPs in *IL1RN* (rs2637988, rs315949) were in high linkage disequilibrium (LD) and may involve in lymphomagenesis (Iii et al., [2011](#mgg31247-bib-0010){ref-type="ref"}). Bensen (Bensen et al., [2003](#mgg31247-bib-0005){ref-type="ref"}) and Buckham(Buckham et al., [2010](#mgg31247-bib-0007){ref-type="ref"}) reported that rs315919 and rs452204 variants have a close correlation with end‐stage renal disease in Caucasians. It is worth noting that rs928940 and rs3181052 have been associated with orthopedic disorders. Jung et al. (Jung et al., [2010](#mgg31247-bib-0011){ref-type="ref"}) reported that rs928940 polymorphism was associated with risk rheumatoid arthritis in a Korean population. Wu et al. (Wu et al., [2013](#mgg31247-bib-0022){ref-type="ref"}) reported that haplotype ACAGATACTGCC constructed by rs3181052 and other SNPs in *IL1RN* was significantly associated with increased risk of knee osteoarthritis in Caucasians. In our study, we have shown that polymorphisms of rs17042888, rs315919, and rs3181052 were related to decreased risk of LDH in our Chinese Han individuals, which provided new evidence for the correlation between these SNPs and orthopedic disorders.

Some intrinsic drawback need to be stated in our study. LDH is a complex disease that influenced by multiple genes and its interaction with a lot of environmental factors. The present study only investigated the associations between *IL1RN* SNPs and LDH risk; hence, the results may be partial and need to be replicated in other populations. In addition, the variables of body mass index and occupation were not taken into consideration due to a lack of data from participants. Therefore, the significant SNPs need to be further demonstrated in a larger sample size composed of different populations and contained specific clinical information.

In summary, the present study demonstrated a close correlation of polymorphic markers in *IL1RN* with the risk of LDH. We have shown that rs17042888, rs315919, and rs3181052 in *IL1RN* may have protective role against risk of LDH, which may be further used for targets of clinical prevention and treatment. Further study will focus on the functional role of *IL1RN* involved in the development of LDH.
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